Basalt Health Pulls $20M Series A to Push Post-Acute Admissions Past the Fax

Basalt Health has raised a $20M Series A led by NEA, a returning investor that first backed the Nashville company in 2025. Frist Cressey Ventures and 25m Health also participated. Basalt says the round brings total capital raised to approximately $24.5M; it reported no valuation and did not separately disclose the size of its prior seed financing.

The company builds AI for post-acute admissions — the step where hospitals, skilled-nursing facilities, inpatient rehabilitation centers, long-term acute-care hospitals and behavioral-health providers have to move clinical records and agree on a placement across organizations that rarely share one clean workflow. Basalt says roughly 14M patients enter post-acute care each year and that a typical placement sends a packet to 6.6 facilities.

The product ingests a referral from fax, portal or direct integration and reads the clinical packet as it arrives. It checks the extracted information against a facility's own clinical and payer criteria, then surfaces red, yellow or green findings with links back to the source document. Basalt describes the system as preparing the decision rather than making it, keeping the clinician responsible for the admission while cutting the chart work needed to understand diagnoses, medications, functional status, coverage and facility-specific risks. The same cited evidence can continue into prior authorization, continued-stay review and appeals. Basalt's security description says customer data is encrypted in transit and at rest, access is logged and limited by role, minimum-necessary PHI is displayed, and the company signs a business associate agreement with every customer.

Rather than asking clinicians to abandon the fax machine, Basalt reads the scanned document and fragmented referral where they already exist, then tries to make the review faster and more consistent without hiding the evidence behind it. That distinction matters in a category where a software rollout can stall if it demands a workflow change before proving it survives real operations.

The customer evidence behind the round is company-reported. Basalt says its Lifepoint Health deployment cut median chart-processing time from 8.5 minutes to 1.2 minutes — an 86% decrease — and that it plans implementation across 49 additional Lifepoint markets by the end of 2026, having been live with Lifepoint since its 2025 seed round. At ScionHealth, Basalt says the platform is scaling to 62 hospitals by year-end and would manage incoming referrals across a network of more than 6,000 practitioners. Those figures establish reported operating traction rather than independently audited outcomes. Axios Pro confirmed the $20M Series A and described growing investor and strategic attention around post-acute administrative workflows.

Basalt will use the money to expand from admissions into discharge and payer workflows and to hire across engineering, implementation, sales and marketing. That expansion would place the same evidence layer across more of the transition — from determining whether a facility can accept a patient to documenting authorization and supporting an appeal when coverage is denied. Enterprise healthcare growth will make those functions as consequential as the model itself, since every new system brings integration work, local criteria, security review, procurement and training.